CP

Caligan Partners Portfolio holdings

AUM $1.41B
1-Year Est. Return 518.95%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+518.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$721M
AUM Growth
+$206M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
21
New
Increased
Reduced
Closed

Top Buys

1
+$45.2M
2
+$16.7M
3
+$16.3M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$15.7M
5
AVTX icon
Avalo Therapeutics
AVTX
+$7.17M

Top Sells

1
+$136M
2
+$28.7M
3
+$13.6M
4
YMAB
Y-mAbs Therapeutics
YMAB
+$10.6M
5
RZLT icon
Rezolute
RZLT
+$6.88M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$185M 25.62%
8,118,892
2
$123M 17.1%
1,451,924
-222,476
3
$105M 14.59%
2,772,654
+755,302
4
$63M 8.74%
1,525,730
5
$49.7M 6.9%
1,064,249
+427,414
6
$45.4M 6.3%
1,131,205
+59,947
7
$38.7M 5.36%
+2,636,609
8
$25.4M 3.53%
4,138,943
+796,973
9
$20.4M 2.83%
216,954
-440,045
10
$17.8M 2.48%
+444,565
11
$13.5M 1.87%
1,435,130
12
$10.6M 1.47%
+833,333
13
$9.75M 1.35%
696,825
+506,875
14
$7.96M 1.1%
+236,383
15
$3.98M 0.55%
923,910
-2
16
$1.4M 0.19%
227,174
+27,174
17
– –
-638,908
18
– –
-1,543,014
19
– –
0
20
– –
-1,436,878
21
– –
-2,342,609